Efrat Aharonovich

4.1k total citations
109 papers, 3.1k citations indexed

About

Efrat Aharonovich is a scholar working on Epidemiology, Pharmacology and General Health Professions. According to data from OpenAlex, Efrat Aharonovich has authored 109 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Epidemiology, 37 papers in Pharmacology and 22 papers in General Health Professions. Recurrent topics in Efrat Aharonovich's work include Substance Abuse Treatment and Outcomes (51 papers), Cannabis and Cannabinoid Research (32 papers) and HIV/AIDS Research and Interventions (21 papers). Efrat Aharonovich is often cited by papers focused on Substance Abuse Treatment and Outcomes (51 papers), Cannabis and Cannabinoid Research (32 papers) and HIV/AIDS Research and Interventions (21 papers). Efrat Aharonovich collaborates with scholars based in United States, Israel and France. Efrat Aharonovich's co-authors include Deborah S. Hasin, Edward V. Nunes, Adam Bisaga, Eliana Greenstein, Dvora Shmulewitz, Adam C. Brooks, Xinhua Liu, Bridget F. Grant, Katherine M. Keyes and Xinhua Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and American Journal of Public Health.

In The Last Decade

Efrat Aharonovich

104 papers receiving 3.1k citations

Peers

Efrat Aharonovich
Margaret L. Griffin United States
Bradley T. Kerridge United States
Mary E. McCaul United States
Robert Miranda United States
Ihsan M. Salloum United States
Susan C. Sonne United States
Sharlene Kaye Australia
Norman S. Miller United States
Efrat Aharonovich
Citations per year, relative to Efrat Aharonovich Efrat Aharonovich (= 1×) peers Michael Soyka

Countries citing papers authored by Efrat Aharonovich

Since Specialization
Citations

This map shows the geographic impact of Efrat Aharonovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efrat Aharonovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efrat Aharonovich more than expected).

Fields of papers citing papers by Efrat Aharonovich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efrat Aharonovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efrat Aharonovich. The network helps show where Efrat Aharonovich may publish in the future.

Co-authorship network of co-authors of Efrat Aharonovich

This figure shows the co-authorship network connecting the top 25 collaborators of Efrat Aharonovich. A scholar is included among the top collaborators of Efrat Aharonovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efrat Aharonovich. Efrat Aharonovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Livne, Ofir, Jacob T. Borodovsky, Alan J. Budney, et al.. (2025). Age Differences in Cannabis Consumption Patterns and in Associations Between Delta-9-Tetrahydrocannabinol Intake and Cannabis Use Disorders Among Adults with Daily Use. Cannabis and Cannabinoid Research. 1327016144–1327016144. 1 indexed citations
2.
Borodovsky, Jacob T., Eilis I Murphy, Deborah S. Hasin, et al.. (2025). Self-titration of cannabis consumption: An epidemiological perspective. Journal of Psychiatric Research. 191. 527–534.
3.
Borodovsky, Jacob T., Deborah S. Hasin, Melanie M. Wall, et al.. (2024). Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers. Addiction. 120(4). 676–685. 9 indexed citations
4.
Knox, Justin, Efrat Aharonovich, Barry S. Zingman, et al.. (2024). HealthCall: Smartphone Enhancement of Brief Interventions to Improve HIV Medication Adherence Among Patients in HIV Care. AIDS and Behavior. 28(6). 1912–1922.
5.
Struble, Cara A., Jacob T. Borodovsky, Ofir Livne, et al.. (2023). Evaluating age-related disparities in cannabis-related problems among LGBT+ versus non-LGBT+ adults. Addictive Behaviors. 148. 107861–107861. 1 indexed citations
6.
Shmulewitz, Dvora, Alan J. Budney, Jacob T. Borodovsky, et al.. (2023). Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. Journal of Psychiatric Research. 163. 211–221. 2 indexed citations
7.
Budney, Alan J., Jacob T. Borodovsky, Cara A. Struble, et al.. (2022). Estimating THC Consumption from Smoked and Vaped Cannabis Products in an Online Survey of Adults Who Use Cannabis. Cannabis and Cannabinoid Research. 9(2). 688–698. 19 indexed citations
8.
Borodovsky, Jacob T., Deborah S. Hasin, Dvora Shmulewitz, et al.. (2022). Typical Hits, Grams, or Joints: Evaluating Cannabis Survey Measurement Strategies for Quantifying Consumption. Cannabis and Cannabinoid Research. 9(2). 646–658. 14 indexed citations
9.
Struble, Cara A., Jacob T. Borodovsky, Deborah S. Hasin, et al.. (2022). Cannabis practices among a gender-diverse sample of young adults. SHILAP Revista de lepidopterología. 5. 100113–100113. 3 indexed citations
10.
Hasin, Deborah S., Jacob T. Borodovsky, Dvora Shmulewitz, et al.. (2021). Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws. Drug and Alcohol Dependence. 229(Pt B). 109159–109159. 31 indexed citations
11.
Shmulewitz, Dvora, Malki Stohl, Eliana Greenstein, et al.. (2021). Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids). Psychological Medicine. 53(5). 1955–1969. 21 indexed citations
12.
Delker, Erin, Efrat Aharonovich, & Deborah S. Hasin. (2016). Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users. Drug and Alcohol Dependence. 161. 29–35. 9 indexed citations
14.
Aharonovich, Efrat, Malka Stohl, James W. Ellis, Paul C. Amrhein, & Deborah S. Hasin. (2013). Commitment strength, alcohol dependence and HealthCall participation: Effects on drinking reduction in HIV patients. Drug and Alcohol Dependence. 135. 112–118. 9 indexed citations
15.
Samet, Sharon, Miriam C. Fenton, Edward V. Nunes, et al.. (2012). Effects of independent and substance‐induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence. Addiction. 108(1). 115–123. 71 indexed citations
16.
Bisaga, Adam, Efrat Aharonovich, Wendy Y. Cheng, et al.. (2010). A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period. Drug and Alcohol Dependence. 111(1-2). 97–104. 45 indexed citations
17.
Mariani, John J., Adam Bisaga, Efrat Aharonovich, et al.. (2008). Antisocial Behavioral Syndromes in Cocaine and Cannabis Dependence. The American Journal of Drug and Alcohol Abuse. 34(4). 405–414. 21 indexed citations
18.
Aharonovich, Efrat, Xinhua Liu, Sharon Samet, et al.. (2005). Postdischarge Cannabis Use and Its Relationship to Cocaine, Alcohol, and Heroin Use: A Prospective Study. American Journal of Psychiatry. 162(8). 1507–1514. 79 indexed citations
19.
Bisaga, Adam, Efrat Aharonovich, Fatima Garawi, et al.. (2005). A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug and Alcohol Dependence. 81(3). 267–274. 68 indexed citations
20.
Hasin, Deborah S., et al.. (2002). Alcohol and ADH2 in Israel: Ashkenazis, Sephardics, and Recent Russian Immigrants. American Journal of Psychiatry. 159(8). 1432–1434. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026